Areas of Clinical Trials

With our global network of sites and principal investigators we are currently planning and managing trials in several clinical areas.

  • Anesthesiology

  • Allergology

  • Cardiology

  • Dermatology

  • Endocrinology

  • Gastroenterology

  • Hematology

  • Neurology

  • Ophthalmology

  • Psychiatry

  • Pulmonology

  • Rheumatology

  • Oncology

    • Head and neck cancer
    • Cancer of breast and soft tissues
    • Oncohematology
    • Lung cancer
    • Cancer of liver and pancreas
    • Gastrointestinal and colorectal cancer
    • Cancer of urea-genital system
    • Musculoskeletal cancer

  • Clinical trials related to surgery

Our Active Clinical Trials

Oncology

  • Clinical study for patients with small cell lung cancer – an open-label study of the effectiveness of combining immunotherapy with chemotherapy compared with standard chemotherapy

    • patients over 18 years old with small cell lung cancer
    • the presence of an archived sample of tumor material
    • a stage of the disease that does not allow for surgical or radiation treatment

  • Clinical study for patients with non-small cell lung cancer – a study  comparing the efficacy and safety of Bevacizumab and its biosimilar, in patients with advanced / recurrent non-squamous cell non-small cell lung cancer, in combination with Paclitaxel and Carboplatin as 1st line therapy.

    • patients over 18 years of age with non-squamous cell non-small cell lung cancer
    • patients with advanced (St IV) or recurrent disease

  • Clinical study for patients with non-small cell lung cancer – an open-label study of the effectiveness of combining immunotherapy with chemotherapy compared to standard chemotherapy

    • patients over 18 years old with non-small cell lung cancer
    • the presence of an archived sample of tumor material
    • patients with advanced (St IV) disease

  • Clinical study for patients with stomach cancer – an open-label study of the effectiveness of immunotherapy compared with standard chemotherapy

    • patients over 18 years of age with stomach cancer
    • the presence of an archived sample of tumor material
    • patients with inoperable disease

  • Clinical study for patients with ovarian cancer – a study of the effectiveness of targeted therapy in patients with positive BRCA mutation

    • patients over 18 years old with ovarian cancer
    • the presence of an archived sample of tumor material

  • Clinical study for patients with colorectal cancer – an open-label study of the effectiveness of combining chemotherapy with Masitinib compared to the best maintenance therapy

    • patients over 18 years old with colorectal cancer
    • patients with advanced (St IV) or recurrent inoperable disease

  • Clinical study for patients with cancer – an open-label study of the efficacy of tableted morphine versus injectable form

    • patients over 18 years of age with any localization and prevalence of cancer
    • chronic pain syndrome requiring the appointment of narcotic analgesics

  • Clinical study for patients with cancer – study of the effectiveness of an anti-thrombotic drug

    • patients over 18 years of age with any localization and prevalence of cancer
    • high risk of thrombotic complications
    • the absence at the time of the study of obvious signs of venous thrombosis

Therapy

  • Clinical study for patients with ulcerative colitis – a study of the effectiveness of biosimilar anti-TNF

    • patients over 18 years of age with an established diagnosis of ulcerative colitis
    • moderate or severe disease activity

  • Clinical study for patients with Crohn’s disease – a study of the effectiveness of biosimilars of anti-TNF

    • patients over 18 years of age with an established diagnosis of Crohn’s disease
    • moderate or severe disease activity

  • Clinical study for patients with rheumatoid arthritis – study of the effectiveness of IL-6 blockers

    • patients over 18 years old with an established diagnosis of rheumatoid arthritis
    • disease activity while taking methotrexate

  • Clinical study for patients with systemic lupus erythematosus – study of the effectiveness of IL-6 blockers

    • patients over 18 years of age with an established diagnosis of systemic lupus erythematosus
    • disease activity against the background of standard therapy

  • Clinical study for patients with type 2 diabetes mellitus – study of the effectiveness of aldosterone inhibitors

    • patients over 18 years of age with an established diagnosis of type 2 diabetes mellitus
    • severe or extremely severe albuminuria as a manifestation of diabetic nephropathy
    • reduced creatinine clearance

  • Clinical study for patients with Alzheimer’s disease – study of the effectiveness of specific therapy

    • patients from 50 to 85 years old
    • burdened heredity due to Alzheimer’s disease
    • reduced memory entry level

Discover The Future

We are dedicated to conducting clinical trials and investigating new medicines and treatments across a broad spectrum of conditions.

Contact Us